Azafaros, een bedrijf in de klinische fase dat zich richt op de ontwikkeling van ziekte-modificerende therapieën om nieuwe behandelingsopties te bieden aan patiënten met zeldzame lysosomale stapelingsziekten, kondigt de voltooiing aan van een overtekende Serie B-financiering van € 132 miljoen onder leiding van Jeito Capital, mede geleid door Forbion Growth en met aanvullende deelname van Seroba, Pictet Group en bestaande investeerders Forbion Ventures, Schroders Capital en BioGeneration Ventures (BGV).

Parkinnova Therapeutics ontvangt financiering van Innovatiefonds Noord-Holland voor de ontwikkeling van een innovatieve behandeling voor de ziekte van Parkinson.

VU spin-off Optics11, partners with Thales to equip Dutch submarines with advanced sonar technology to enhance underwater surveillance capabilities.

Explore the journeys of UvA Researchers Tijmen Bakker, Olivier Lugier, and Ewelina Weglarz-Tomczak as they transformed their research into impactful startups.

RehabAI@Home elevates innovation in rehabilitation care by combining science, artificial intelligence (AI), and entrepreneurship, making home rehabilitation more accessible and effective.

Madglove has secured the full Rabobank Innovation Loan. This funding enables the company to continue its mission of viewing disabilities as a form of diversity and providing innovative solutions for individuals with physical limitations.

The new call focuses on the five themes of mission-driven innovation policy: Energy, Safety, Health, Agriculture, and Circular Economy.

Four researchers from Amsterdam have been selected for the intensive two-year program of the Faculty of Impact. They will have the opportunity to transform their scientific research into scalable or commercial startups with societal impact.

The Take-off grant empowers academics to explore the feasibility and commercial potential of their science-based ideas, and even consider starting businesses based on their innovations.